Advisor Group Holdings, Inc. Kezar Life Sciences, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $39.8 Billion
  • Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,686 shares of KZR stock, worth $21,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,686
Previous 4,666 21.0%
Holding current value
$21,710
Previous $3,000 700.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$0.74 - $8.19 $725 - $8,026
-980 Reduced 21.0%
3,686 $24,000
Q3 2024

Nov 13, 2024
BUY
$0.53 - $0.77 $1,953 - $2,838
3,686 Added 376.12%
4,666 $3,000
Q2 2024

Aug 13, 2024
BUY
$0.6 - $0.92 $543 - $832
905 Added 1206.67%
980 $0
Q1 2024

May 10, 2024
SELL
$0.8 - $1.05 $48 - $63
-60 Reduced 44.44%
75 $0
Q2 2023

Aug 10, 2023
SELL
$2.31 - $3.06 $1,157 - $1,533
-501 Reduced 78.77%
135 $0
Q1 2023

May 12, 2023
SELL
$3.13 - $7.31 $5,164 - $12,061
-1,650 Reduced 72.18%
636 $1,000
Q3 2022

Nov 14, 2022
BUY
$7.99 - $10.75 $399 - $537
50 Added 2.24%
2,286 $20,000
Q2 2022

Aug 10, 2022
BUY
$4.58 - $17.13 $9,622 - $35,990
2,101 Added 1556.3%
2,236 $18,000
Q1 2022

May 04, 2022
BUY
$12.3 - $18.33 $1,660 - $2,474
135 New
135 $2,000

Others Institutions Holding KZR

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $403M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email